Alex Brill Featured in Axios Live
Alex Brill was recently quoted in Julie Bogen’s article “Axios Live: Biosimilars face barriers beyond science.” The article summarizes a recent Axios’ roundtable discussion July 23 sponsored by Sandoz.
“Made in America” is often “in conflict with an affordability agenda,” said American Enterprise Institute senior fellow Alex Brill, and tradeoffs may be needed with the source of “safe, well-manufactured” drugs.
Read the full article here.
